Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Moody's
MCO
5
Jefferies Financial
JEF
HK Stock MarketDetailed Quotes
02256 ABBISKO-B
- 7.950
- +0.280+3.65%
Market Closed May 2 16:08 CST
5.39BMarket Cap176.67P/E (TTM)
7.980High7.540Low2.08MVolume7.600Open7.670Pre Close16.31MTurnover0.31%Turnover Ratio176.67P/E (Static)678.09MShares8.98052wk High2.55P/B5.39BFloat Cap2.73052wk Low--Dividend TTM678.09MShs Float12.540Historical High--Dividend LFY5.74%Amplitude2.050Historical Low7.839Avg Price1000Lot Size--Div YieldTTM--Div Yield LFY
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts
ABBISKO-B Stock Forum
On April 1 2025, Abbisko Therapeutics Co., Ltd. (“Abbisko Therapeutics”) announced that Merck has exercised the global commercialization option for pimicotinib(ABSK021), with an option exercise fee of USD85.0 million, under the licensing agreement signed in December 2023. The development represents further deepening of the collaboration, underscoring the unwavering commitment and confidence tha...
No comment yet